Clinical Trials Directory

Trials / Completed

CompletedNCT05390294

Survival With Patients Treated With Salivary Gland Cancer

Prognostic Factors for Survival of Patients With Salivary Gland Malignancies

Status
Completed
Phase
Study type
Observational
Enrollment
250 (actual)
Sponsor
Clinical Center of Vojvodina · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Salivary gland malignancies is very heterogenous group of tumors regarding tumor histology and localization. The aim of this study is to assess main clinical and pathological parameters related to patients survival

Detailed description

The retrospective study enrolled medical charts of the patients treated due to salivaly gland cancers in the Clinic for maxillofacial surgery at Clinical center of Vojvodina in the period of 1. January 1996. to 31. December 2021. Patients demographics, type of the tumor, localization, TNM status and patohystological parameters were evaluated for patients survival and disease free periods

Conditions

Interventions

TypeNameDescription
PROCEDURESurgical intervention with or without postoperative adjuvant therapySurgical intervention with or without postoperative adjuvant therapy

Timeline

Start date
2022-01-01
Primary completion
2022-03-30
Completion
2022-04-30
First posted
2022-05-25
Last updated
2022-05-25

Locations

1 site across 1 country: Serbia

Source: ClinicalTrials.gov record NCT05390294. Inclusion in this directory is not an endorsement.